This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Aventis Pharmaceuticals Inc., Mars, Incorporated. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2025
I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.
Title: Innovator Spotlight - David Stefany from Hillsborough, NJ
Introduction:
David Stefany, a skilled inventor hailing from Hillsborough, NJ, has made significant contributions to the field of pharmaceuticals through his groundbreaking patents. With a keen eye for scientific innovation, Stefany has successfully secured two patents, showcasing his expertise and dedication to revolutionizing healthcare.
Latest Patents:
- 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists: Stefany's invention presents a compound formula aimed at treating PGD2-mediated disorders such as allergic diseases, bronchitis, urticaria, and chronic rheumatoid arthritis. This patent underscores Stefany's commitment to advancements in pharmaceutical treatments.
- Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP): Stefany's second patent focuses on a series of pyridone derivatives that serve as PARP inhibitors, offering potential in the treatment of diseases related to the central nervous and cardiovascular systems. This invention demonstrates Stefany's versatility in developing therapeutic solutions.
Career Highlights:
David Stefany's professional journey showcases his affiliation with Aventis Pharmaceuticals Inc., a renowned player in the pharmaceutical industry. His association with such a prestigious company reflects his capability to thrive in a competitive and innovative work environment, contributing significantly to the advancement of pharmaceutical research and development.
Collaborations:
Throughout his career, Stefany has collaborated with accomplished individuals like Sungtaek Lim and Keith John Harris. These collaborations have not only enriched Stefany's work but have also led to the successful development of pioneering pharmaceutical solutions. His ability to work effectively in a team highlights his collaborative spirit and commitment to collective progress.
Conclusion:
In conclusion, David Stefany stands out as a prominent inventor with a passion for advancing pharmaceutical sciences. His patents exemplify his dedication to addressing critical healthcare needs and improving patient outcomes. Stefany's collaborative nature and association with Aventis Pharmaceuticals Inc. underscore his commitment to innovation and excellence in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile